Viking Therapeutics, Inc. (VKTX)
32.01
-0.12
(-0.37%)
USD |
NASDAQ |
Sep 11, 16:00
32.01
0.00 (0.00%)
After-Hours: 18:22
Viking Therapeutics Gross Profit (TTM) : -0.45M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.45M |
| March 31, 2026 | -0.405M |
| December 31, 2025 | -0.431M |
| September 30, 2025 | -0.447M |
| June 30, 2025 | -0.42M |
| March 31, 2025 | -0.383M |
| December 31, 2024 | -0.346M |
| September 30, 2024 | -0.31M |
| June 30, 2024 | -0.296M |
| March 31, 2024 | -0.294M |
| December 31, 2023 | -0.292M |
| September 30, 2023 | -0.29M |
| June 30, 2023 | -0.359M |
| March 31, 2023 | -0.286M |
| December 31, 2022 | -0.291M |
| September 30, 2022 | -0.295M |
| June 30, 2022 | -0.228M |
| March 31, 2022 | -0.301M |
| December 31, 2021 | -0.296M |
| September 30, 2021 | -0.291M |
| June 30, 2021 | -0.286M |
| March 31, 2021 | -0.281M |
| December 31, 2020 | -0.277M |
| September 30, 2020 | -0.206M |
| June 30, 2020 | -0.136M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.068M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.94B |
| Eli Lilly & Co. | 66.44B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Amgen, Inc. | 27.78B |
| Ironwood Pharmaceuticals, Inc. | 387.48M |